The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up insulin prices through anticompetitive and unfair rebating practices, ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that ...

The latest lawsuit, which comes as the middlemen in the drug supply chain face growing criticism over their role in high drug costs, alleges the companies used their market size to conspire with ...

These pharmacy benefits managers, also known as PBMs, are either owned or connected to health insurance providers and are intended to facilitate negotiations with pharmaceutical manufacturers and ...

WASHINGTON (AP) — The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three ...